INS and type 1 diabetes mellitus: Modeling the BSV and WSV of the subcutaneous kinetics of fast-acting insulin analogues represents an important step in understanding this phenomenon, which may help in better simulating the complex behavior of the glucose regulatory system and, in turn, improving both T1D and T2D management.